Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Interest Income - Net (2019 - 2026)

Immatics (IMTX) posted Interest Income - Net of -$45.1 million for Q4 2025, down 965.7% sequentially from -$4.2 million in Q3 2025, and down 541.2% YoY from $10.2 million in Q4 2024.

Analysis

Immatics (IMTX) Interest Income - Net (2019 - 2026) Analysis & Trends

Immatics has reported Interest Income - Net for 7 years, with the latest figure at -$45.1 million in Q4 2025.

  • Quarterly Interest Income - Net fell 541.2% year-over-year to -$45.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$71.7 million (down 470.39% YoY) and the FY2025 annual result came in at -$60.8 million, down 137.36% from the prior year.
  • Interest Income - Net eased to -$45.1 million in Q4 2025 per IMTX's latest filing, from -$4.2 million in the prior quarter.
  • Over five years, Interest Income - Net peaked at $8.3 million in Q1 2025 and troughed at -$45.1 million in Q4 2025.
  • A 5-year average of -$3.9 million and a median of $12834.9 in 2021 frame the typical range for Interest Income - Net.
  • The sharpest annual moves came in 2022 and 2023: Interest Income - Net surged 1248.05% in 2022, then slumped 1563.5% in 2023.
  • Over 5 years, Interest Income - Net stood at $337471.4 in 2021, then soared by 1248.05% to $4.5 million in 2022, then sank by 59.36% to $1.8 million in 2023, then slumped by 480.59% to -$7.0 million in 2024, then plunged by 541.2% to -$45.1 million in 2025.
  • According to Business Quant data, Interest Income - Net over the past three periods registered -$45.1 million, -$4.2 million, and -$30.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Income - Net (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Immatics 1.17 Bn 711.21 Mn - -235,959.46
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -235,959.46
Mar 31, 2026 -248,198.08
Dec 31, 2025 -258,417.66
Sep 30, 2025 -270,051.73
Jun 30, 2025 -276,198.16
Mar 31, 2025 -261,919.23
Dec 31, 2024 -247,914.13
Sep 30, 2024 -256,983.36
Jun 30, 2024 -243,376.59
Mar 31, 2024 -210,754.18
Dec 31, 2023 -74,239.85
Sep 30, 2023 -81,644.29
Jun 30, 2023 -72,957.93
Mar 31, 2023 -84,794.00
Dec 31, 2022 -177,523.04
Sep 30, 2022 -87,719.87
Jun 30, 2022 -290,239.42
Mar 31, 2022 -181,818.71
Dec 31, 2021 -891,153.37
Sep 30, 2021 86,087.97